Regeneration Technologies, Inc.
This article was originally published in The Gray Sheet
Executive Summary
Alachua, Fla. firm plans to conduct clinical trials to extend use of its BioCleanse sterilization process to RTI heart valves and osteochondral grafts. Available since March 2000, the process currently is used to sterilize the company's bone tissue products. Beginning March 1, the latter RTI products will be labeled "sterile" for the first time based on ISO and AAMI standards. RTI announced the "official" launch of the BioCleanse system encompassing product and package sterilization processes Feb. 5...